Abstract
There is a controversy regarding the optimal time to assess anal squamous cell carcinoma (SCC) response to chemoradiation and when salvage abdominoperineal resection (APR) should be offered. A retrospective cohort study was performed on patients with stage I-III anal SCC treated with chemoradiation in the National Cancer Database (2004-2015). The time between radiation and APR was recorded. Logistic regression and Cox proportional hazard analysis were used to determine predictors of resection margin status and overall survival. The cohort included 23 050 patients, of whom 545 (2.4%) underwent salvage APR. The median (IQR) time between radiation and resection was 3.8 (2.4-5.5) months. The rate of positive margins was 19.0%. Positive margins were more common in male, non-white patients with larger tumors, pathologic upstaging of T stage, and ≥3 months between chemoradiation and resection (all P < .05). Observing for ≥3 months between chemoradiation and APR remained associated with positive margins, even after adjusting for pretreatment tumor size (odds ratio = 2.56, 95% CI 1.46-4.47). Our data, based on the largest published cohort of anal SCC patients treated with chemoradiation and subsequent APR, suggest that patients at high ...Continue Reading
References
Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
May 1, 1974·Diseases of the Colon and Rectum·N D NigroB Considine
Nov 15, 1995·Cancer·J A MartensonD G Haller
Nov 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Julie K SchwarzPerry W Grigsby
Jul 28, 2011·British Journal of Cancer·F L DayA Heriot
Mar 23, 2012·International Journal of Radiation Oncology, Biology, Physics·Anne Gry BentzenLise Balteskard
Sep 22, 2012·AJR. American Journal of Roentgenology·Uday B PatelGina Brown
Nov 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard L GundersonChristopher G Willett
Sep 17, 2013·International Journal of Radiation Oncology, Biology, Physics·Leonard L GundersonChristopher G Willett
May 16, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R Glynne-JonesUNKNOWN ACT II Study Group
Jul 9, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R Glynne-JonesD Arnold
Mar 31, 2015·Annals of Surgery·Nicholas J BattersbyUNKNOWN MERCURY II Study Group
Aug 1, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Meredith S ShielsSusan S Devesa
Jul 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jérémie H LefevreEmmanuel Tiret
Feb 18, 2017·The Lancet Oncology·Robert Glynne-JonesUNKNOWN ACT II study group
Feb 18, 2017·The Lancet Oncology·Angelita Habr-GamaRodrigo Oliva Perez
Jan 5, 2018·Journal of Gastrointestinal Oncology·Jaymin JhaveriJerome C Landry
Jan 18, 2018·Diseases of the Colon and Rectum·Glen R GuerraAlexander G Heriot
Jul 15, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonDeborah A Freedman-Cass
Jan 4, 2019·Journal of Gastrointestinal Oncology·Stephen J RameyRaphael Yechieli
Jan 29, 2019·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G KoS V Patel